Avitriptan

Avitriptan

SCHEMBL29633456

CNS(=O)(=O)Cc1ccc2[nH]cc(CCCN3CCN(c4ncncc4OC)CC3)c2c1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 4/20 0.55
HTR1B P28222 4/20 0.55
HTR1A P08908 9/20 0.47
HTR7 P34969 2/20 0.47
SLC6A4 P31645 1/20 0.47
KCNH2 Q12809 1/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 1/20 0.47
HTR1E P28566 1/20 0.47
HTR1F P30939 1/20 0.47
HTR2B P41595 1/20 0.47
HTR3A P46098 1/20 0.47
HTR5A P47898 1/20 0.47
SLC47A1 Q96FL8 1/20 0.47
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Avitriptan SCHEMBL147315 1.00 HTR1D (0.55) HTR1DHTR1BHTR1AHTR7SLC6A4
Avitriptan SCHEMBL4352074 0.99 HTR1D (0.54) HTR1DHTR1BHTR1AHTR7SLC6A4
SCHEMBL9045333 0.95 HTR1D (0.49) HTR1DHTR1BHTR1AHTR7SLC6A4
SCHEMBL4349219 0.91 HTR1A (0.49) HTR1AHTR7SLC6A4KCNH2ADRA2A
SCHEMBL6363083 0.91 HTR1A (0.49) HTR1AHTR7SLC6A4KCNH2ADRA2A
SCHEMBL4346029 0.90 HTR1A (0.48) HTR1DHTR1BHTR1AHTR7SLC6A4
SCHEMBL4345058 0.89 HTR1A (0.47) HTR1AHTR7SLC6A4KCNH2ADRA2A
Avitriptan SCHEMBL18396454 0.89 HTR1A (0.57) HTR1DHTR1BHTR1AHTR7SLC6A4
SCHEMBL6362007 0.88 HTR1D (0.51) HTR1DHTR1BHTR1AHTR7SLC6A4
Hydrochloric Acid SCHEMBL4349599 0.88 HTR1A (0.48) HTR1AHTR7SLC6A4KCNH2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114462-A1 MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS Belhaven BioPharma Inc. (US) 2023-06-22 WO disclosed
EP-3989970-A1 TRIPTAN MICROPORATION DELIVERY SYSTEM PassPort Technologies, Inc. (US) 2022-05-04 EP disclosed